$13.6 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 97 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PLYA | PLAYA HOTELS & RESORTS NV | $220,064,000 | -25.3% | 30,606,930 | 0.0% | 1.61% | -7.4% | |
| TLRY | TILRAY INC | $162,074,000 | -43.2% | 2,479,515 | 0.0% | 1.19% | -29.5% | |
| RDUS | RADIUS HEALTH INC | $33,692,000 | -7.4% | 2,043,149 | 0.0% | 0.25% | +14.9% | |
| SHPG | SHIRE PLCsponsored adr | $15,204,000 | -3.6% | 87,000 | 0.0% | 0.11% | +19.4% | |
| APTX | APTINYX INC | $11,082,000 | -42.9% | 670,000 | 0.0% | 0.08% | -29.6% | |
| ZEAL | ZEALAND PHARMA A Ssponsored adr | $10,449,000 | -29.7% | 900,000 | 0.0% | 0.08% | -12.5% | |
| VYGR | VOYAGER THERAPEUTICS INC | $8,546,000 | -50.3% | 909,158 | 0.0% | 0.06% | -38.2% | |
| VOYA | VOYA FINL INC | $7,426,000 | -19.2% | 185,000 | 0.0% | 0.05% | 0.0% | |
| GCVRZ | SANOFIright 12/31/2020 | $3,277,000 | -14.3% | 6,827,805 | 0.0% | 0.02% | +4.3% | |
| ITCI | INTRA CELLULAR THERAPIES INC | $2,848,000 | -47.5% | 250,000 | 0.0% | 0.02% | -34.4% | |
| PFNX | PFENEX INC | $1,914,000 | -37.6% | 600,000 | 0.0% | 0.01% | -22.2% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 41 | Q3 2023 | 3.7% |
| RADIUS HEALTH INC | 33 | Q2 2022 | 1.7% |
| GRIFOLS S A | 33 | Q4 2021 | 0.9% |
| ALPHABET INC | 32 | Q3 2023 | 4.2% |
| SPDR S&P 500 ETF TR | 31 | Q3 2023 | 25.3% |
| VISA INC | 30 | Q3 2023 | 2.9% |
| WABTEC CORP | 27 | Q3 2023 | 3.6% |
| EXELIXIS INC | 27 | Q3 2023 | 2.8% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 2.6% |
| SAVARA INC | 26 | Q3 2023 | 0.3% |
View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Atento S.A. | March 15, 2023 | 2,230,357 | 15.4% |
| Metals Acquisition Corp | February 07, 2023 | 2,489,700 | 9.4% |
| Inflection Point Acquisition Corp. | February 06, 2023 | 1,900,000 | 5.8% |
| AMYRIS, INC. | February 24, 2022 | 1,068,904 | 0.3% |
| Swiftmerge Acquisition Corp. | February 14, 2022 | 291,060 | 1.3% |
| Caribou Biosciences, Inc. | February 11, 2022 | 2,428,150 | 4.0% |
| ENANTA PHARMACEUTICALS INC | February 11, 2022 | 287,000 | 1.4% |
| Protagonist Therapeutics, Inc | February 11, 2022 | 387,051 | 0.8% |
| Solid Power, Inc. | February 11, 2022 | ? | ? |
| Better Therapeutics, Inc. | February 09, 2022 | 124,065 | 0.5% |
View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-05-15 |
| 13F-HR/A | 2024-05-15 |
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR | 2024-02-14 |
View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.